PyInvesting

Market research

3613.HK Beijing Tong Ren Tang Chinese Medicine Company Limited

HK HKD Healthcare

Latest close

5.34 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
5B
P/E ratio
13.43
Analyst target
9.75
Dividend yield
6.5%
Beta
0.38

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Beijing Tong Ren Tang Chinese Medicine Company Limited is currently in a long term uptrend where the price is trading 27.5% above its 200 day moving average.

From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.1.

Beijing Tong Ren Tang Chinese Medicine Company Limited's total revenue rose by 22.6% to $748M since the same quarter in the previous year.

Its net income has increased by 59.9% to $316M since the same quarter in the previous year.

Finally, its free cash flow fell by 76.1% to $27M since the same quarter in the previous year.

Based on the above factors, Beijing Tong Ren Tang Chinese Medicine Company Limited gets an overall score of 4/5.